Qube Research & Technologies (QRT)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-65,571
Closed -$487K 3869
2026
Q1
$487K Buy
+65,571
New +$690K ﹤0.01% 2743
2025
Q3
Sell
-108,847
Closed -$796K 3836
2025
Q2
$796K Buy
+108,847
New +$878K ﹤0.01% 2552
2025
Q1
Sell
-21,083
Closed -$347K 3743
2024
Q4
$347K Sell
21,083
-40,135
-66% -$623K ﹤0.01% 2647
2024
Q3
$903K Buy
+61,218
New +$958K ﹤0.01% 2066
2024
Q2
Sell
-16,545
Closed -$260K 4435
2024
Q1
$260K Buy
+16,545
New +$255K ﹤0.01% 2894
2023
Q4
Sell
-140,879
Closed -$1.73M 4605
2023
Q3
$1.73M Buy
140,879
+106,781
+313% +$1.59M ﹤0.01% 1453
2023
Q2
$548K Buy
34,098
+17,021
+100% +$281K ﹤0.01% 1493
2023
Q1
$297K Sell
17,077
-70,260
-80% -$1M ﹤0.01% 1762
2022
Q4
$807K Buy
+87,337
New +$814K ﹤0.01% 1310
2022
Q2
Sell
-19,252
Closed -$234K 2917
2022
Q1
$234K Buy
+19,252
New +$405K ﹤0.01% 1889
2020
Q2
Sell
-7,972
Closed -$220K 1902
2020
Q1
$220K Sell
7,972
-6,940
-47% -$208K 0.01% 840
2019
Q4
$436K Buy
+14,912
New +$355K 0.01% 1027

Other funds holding NEO

Qube Research & Technologies (QRT)'s NEO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 65,571 shares — an estimated $487K sold.

Qube Research & Technologies (QRT) first reported a position in NEO in Q4 2019 and held it in 12 quarters. The position peaked at $1.73M in Q3 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 65,571 NeoGenomics shares in Q2 2026, an estimated $487K.
  • Qube Research & Technologies (QRT) first reported a position in NeoGenomics in Q4 2019 and held it in 12 quarters.
  • Qube Research & Technologies (QRT)'s NeoGenomics position peaked at $1.73M in Q3 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.